Neurotoxicity: A Rare Side Effect of Programmed Cell Death 1 (PD-1) Inhibitors

Immunotherapy is a biological therapy that helps the body’s immune system to fight against cancer cells. The Food and Drug Administration (FDA) approved the first immune checkpoint inhibitor in 2011. Since 2011, many immune checkpoint inhibitors have been approved. Programmed cell death 1 (PD-1) inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehsanullah, Syed, Hasan, Syed, Polani, Faran S, Rashid, Syeda zarmeena, Ahmed, Syed Ijlal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957660/
https://www.ncbi.nlm.nih.gov/pubmed/35355539
http://dx.doi.org/10.7759/cureus.22584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957660/
https://www.ncbi.nlm.nih.gov/pubmed/35355539
http://dx.doi.org/10.7759/cureus.22584

Ejemplares similares